Results 51 to 60 of about 4,685 (255)

Remimazolam Anesthesia for Thyroid Surgery

Case Reports in Anesthesiology, 2023
Background. Critical upper airway obstruction, hematoma formation, and recurrent laryngeal nerve palsy have been reported as postoperative complications of thyroid surgery. Although remimazolam may reduce the risk of these complications, the efficacy of flumazenil with remimazolam has not been reported.
Sae Nakagawa, Tomoharu Shakuo, Sakurako Matsudo, Hiroaki Soda, Kenji Shida   +4 more
openaire   +3 more sources

Relationship between age and remimazolam dose required for inducing loss of consciousness in older surgical patients

Frontiers in Medicine
BackgroundRemimazolam is a new ultra-short-acting benzodiazepine for procedural sedation and general anaesthesia, characterised by rapid onset of action, quick recovery, and organ-independent metabolism.
Jin-Chao Song, Xiao-xi Wang, Xiang Fu, Wei Chen, Shu-heng Tang, Fang Deng, Hua Yang, Wen Liu   +7 more
doaj   +1 more source

Pharmacokinetics and pharmacodynamics of remimazolam for procedural sedation in children and adolescents [PDF]

BACKGROUND/INTRODUCTION: Remimazolam is not approved for use in pediatric patients. The pharmacokinetics of remimazolam have been reported to be similar to those of adult patients after scaling for body size.
Bichajian, Lynn H, Colin, Pieter J, Curt, Valentin R, Koomen, Jeroen V, Mason, Keira P, Struys, Michel M R F, Stöhr, Thomas   +6 more
core   +1 more source

Hypotension during propofol sedation for colonoscopy:an exploratory analysis [PDF]

, 2021
BACKGROUND: Intraoperative and postoperative hypotension occur commonly and are associated with organ injury and poor outcomes. Changes in arterial blood pressure (BP) during procedural sedation are not well described.
Absalom, Anthony R, Barends, Clemens R M, Jones, Jordan B, Sneyd, J Robert   +3 more
core   +2 more sources

Postoperative Heart Failure with Preserved Ejection Fraction Induced by Flumazenil Administered for Remimazolam Antagonism

Case Reports in Anesthesiology, 2022
Remimazolam is an ultrashort-acting benzodiazepine intravenous anesthetic characterized by rapid awakening after anesthesia. However, the method for administering remimazolam in clinical practice remains unclear.
Keito Koh, Takeshi Omae, Sonoko Sakuraba, Masateru Kumemura, Sho Yamazaki, Hiroshi Yunoki   +5 more
doaj   +1 more source

Anesthetic management with remimazolam in a patient with inclusion body myositis: a case report [PDF]

, 2023
Background: Inclusion body myositis (IBM), an inflammatory muscle disease, sometimes leads to swallowing impairment. The anesthetic management of patients with IBM should be carefully performed to prevent the development of postoperative pulmonary ...
Hara, Tetsuya, Maekawa, Takuji, Miyazaki, Yuri, Shintani, Ryosuke, Tanaka, Tatsuhito, Tashiro, Keiko, Teshima, Taku, Ura, Hanako   +7 more
core  

Mapping the Clinical Evidence on Remimazolam in Anaesthesia: A Protocol for a Scoping Review

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 6, July 2026.
ABSTRACT Background Remimazolam is a recently introduced benzodiazepine used for procedural sedation and general anaesthesia. Its pharmacokinetic profile, including rapid metabolism and predictable recovery, has generated interest in its potential advantages compared with traditional sedatives such as midazolam and propofol.
Emma Hansine Vangsgaard Skuldbøl Nilsson, Ibrahim Abood, Ann Merete Møller   +2 more
wiley   +1 more source

The Effect of Remimazolam Administration on Emergence Delirium in Children After General Anesthesia: A Systematic Review With Meta‐Analysis of Randomized Controlled Trials

Pediatric Anesthesia, Volume 36, Issue 6, Page 628-640, June 2026.
ABSTRACT Background Emergence delirium commonly occurs in pediatric patients after general anesthesia, causing distress and potential harm. Remimazolam, an ultra‐short‐acting benzodiazepine, has recently been introduced in pediatric anesthesia, but its preventive role against emergence delirium remains unclear.
Ji‐Na Kim, Hyo‐Seok Na, Hyun‐Jung Shin   +2 more
wiley   +1 more source

Remimazolam Protects Against LPS-Induced Endotoxicity Improving Survival of Endotoxemia Mice

Frontiers in Pharmacology, 2021
Remimazolam is a new benzodiazepine of sedative drugs with an ultra-short-acting anesthetic effect, commonly used for critically ill patients (especially septic patients) in intensive care units (ICUs).
Xiaolei Liu, Shaoping Lin, Yiyue Zhong, Jiaojiao Shen, Xuedi Zhang, Shuhua Luo, Li Huang, Liangqing Zhang, Shuangnan Zhou, Jing Tang   +9 more
doaj   +1 more source

Remimazolam: a randomised controlled study of its suitability for insertion of a supraglottic airway [PDF]

獨協医科大学博士（医学）令和5年度doctoral ...
有銘, 勇登
core   +1 more source